Summer Linea

Summer Linea

Integratore alimentare a base di Polyporus umbellatus, piante e gemmoderivati utile per attivare il metabolismo e favorire l'equilibrio del peso corporeo,  contribuendo a stimolare il microcircolo e contrastando gli inestetismi della cellulite

 Finalità Salutistiche:

Summer Linea è un estratto di erbe in acqua energizzata a base di Polyporus umbellatus, piante e gemmoderivati studiato per favorire l’eliminazione delle tossine e dei liquidi ristagnati a livello intercellulare, ridurre l’infiammazione e sostenere il metabolismo. Grazie alla sinergia dei suoi componenti Summer linea stimola la diuresi e la circolazione venosa, migliora il drenaggio linfatico e nello stesso tempo contribuisce ad attivare il metabolismo favorendo una fisiologica riduzione del peso corporeo.

 


Ingredienti:

Estratto di mela dolce, Fumaria officinalis erba, Centella asiatica erba ed estratto secco tit.40% triterperni, Fucus vesiculosus L. tallo ed estratto secco tit. 0,1% in iodio, potassio gluconato, estratto di Polyporus umbellatus; gemmoderivati di: Castanea vesca, Sorbus domestica, betacarotene. Acidificanti: acido lattico, acido citrico. Aroma


Proprietà dei componenti:

  • Fumaria officinalis: depurativa, diuretica, antinfiammatoria. Presenta una notevole attività coleretica e di drenaggio epatobiliare; stimola la funzionalità del pancreas esocrino e favorisce la regolazione del flusso biliare. Svolge un ruolo importante nel controllo del peso, migliora l’eliminazione tossinica epato-biliare e il rapporto massa magra/massa grassa. Favorisce il metabolismo lipidico epatico ed esercita un’azione positiva anche nel metabolismo degli zuccheri.
  • Centella asiatica: azione antinfiammatoria, antivaricosa e fluidificante del sangue. Aumenta l’ossigenazione cerebrale, migliorando la lucidità mentale, la concentrazione e i ritmi del sonno. Stimola la circolazione venosa, migliora la vascolarizzazione tissutale e prove cliniche hanno evidenziato la sua efficacia nel trattamento della cellulite.
  • Fucus tallo: ricco in vitamine oligoelementi e sali minerali, è considerato un’alga brucia-grassi, infatti attiva il metabolismo attraverso il sostegno tiroideo, facilitando la perdita di peso. Inoltre esercita azione depurativa, dimagrante e tonificante metabolica
  • Potassio gluconato: fonte di potassio, un elemento fondamentale poiché rappresenta il principale ione intracellulare, importante per la salute del sistema cardiovascolare. Utile in caso di ritenzione idrica poiché contribuisce all’eliminazione del sodio in eccesso e quindi dei liquidi in eccesso
  • Polyporus umbellatus: si tratta di un rimedio ad azione diuretica, che esplica la sua azione soprattutto in presenza di ritenzione idrica, edemi e difficoltà nella minzione. Non provoca effetti collaterali in quanto permette l’eliminazione di sodio e cloro ma conserva il potassio. Utile in presenza di stasi linfatica
  • Castanea vesca gemmoderivato: svolge un’azione di drenaggio linfatico, utile in caso di stasi linfatica degli arti inferiori, edemi di natura linfatica, varici, varicosità, tromboflebiti emorroidi
  • Sorbus domestica gemmoderivato: utile in caso di insufficienza venosa poiché regola la circolazione e tonifica le pareti vasali venose. Fluidificante ematico e protettivo vascolare.
  • Betacarotene: utile per preparare la pelle all’abbronzatura

Modalità d’uso:

1 misurino (20 ml) due volte al giorno preferibilmente lontano dai pasti diluito in un bicchiere d’acqua.


Confezione:

flacone da 500 ml


Note:

conservare in luogo fresco e asciutto. Dopo l’apertura conservare in frigorifero.


Codice EAN: A926888948


tenore medio degli ingredienti caratterizzanti per dose giornaliera (40 ml) VNR *
Fumaria erba 2,4 g
Centella erba 1,2 g
Fucus tallo 1,2 g
Polyporus umbellatus 800 mg

Centella estratto secco

apporto in triterpeni

400 mg

160 mg

Potassio 300 mg 15%

Fucus estratto secco

apporto in iodio

225 mg

225 mcg

 

150%

Castanea vesca gemmoderivato 160 mg
Sorbus domestica gemmoderivato 160 mg
Betacarotene 2,4 mg 48 %

*Valori Nutritivi di Riferimento



Bibliografia:

1. Incandela L, Cesarone MR, Cacchio M, De Sanctis MT, Santavenere C, D’Auro MG, Bucci M, Belcaro G.Total triterpenic fraction of Centella asiatica in chronic venous insufficiency and in high-perfusion microangiopathy. Angiology. 2001 Oct; 52 Suppl 2:S9-13)
2. (Cesarone MR, Laurora G, De Sanctis MT, Belcaro G. Activity of Centella asiatica in venous insufficiency. Minerva Cardioangiol 1992; 40: 137-43).
3. Cesarone MR, Laurora G, De Sanctis MT, Incandela L, Grimaldi R, Marelli C, Belcaro G. The microcirculatory activity of Centella asiatica in venous insufficiency. A double-blind study. Minerva Cardioangiol 1994; 42: 299-304).
4. Incandela L, Belcaro G, De Sanctis MT, Cesarone MR, Griffin M, Ippolito E, Bucci M, Cacchio M. Total triterpenic fraction of Centella asiatica in the treatment of venous hypertension: a clinical, prospective, randomized trial using a combined microcirculatory model. Angiology. 2001 Oct; 52 Suppl 2:S61-7).
5. Incandela L, Belcaro G, De Sanctis MT, Cesarone MR, Griffin M, Ippolito E, Bucci M, Cacchio M. Total triterpenic fraction of Centella asiatica in the treatment of venous hypertension: a clinical, prospective, randomized trial using a combined microcirculatory model. Angiology. 2001 Oct; 52 Suppl 2:S61-7).
6. Belcaro GV, Grimaldi R, Guidi G. Improvement of capillary permeability in patients with venous hypertension after treatment with TTFCA. Angiology 1990; 41: 533-40).
7. Arpaia MR, Ferrone R, Amitrano M, Nappo C, Leonardo G, del Guercio R. Effects of Centella asiatica extract on mucopolysaccharide metabolism insubjects with varicose veins. Int J Clin Pharmacol Res 1990; 10: 229-33).
8. Montecchio GP, Samaden A, Carbone S, Vigotti M, Siragusa S, Piovella F. Centella Asiatica Triterpenic Fraction (CATTF) reduces the number of circulating endothelial cells in subjects with post phlebitic syndrome. Haematologica 1991; 76: 256-9).
9. Kim YN, Park YS, Kim HK, Jeon BC, Youn SE, Lee HY. Enhancement of the attachment on microcarriers and tPA production by fibroblast cells in a serum-free medium by the addition of the extracts of Centella asiatica. Phytotechnology 1993; 13: 221-6).
10. Bonte F, Dumas M, Chaudagne C, Meybeck A. Influence of asiatic acid, madecassic acid, and asiaticoside on human collagen I synthesis. Planta Med 1994; 60: 133-5).
11. Maquart FX, Bellon G, Gillery P, Wegrowski Y, Borel JP. Stimulation of collagen synthesis in fibroblast cultures by a triterpene extracted from Centella asiatica. Connect Tissue Res 1990; 24: 107-20).
12. Bonte F, Dumas M, Chaudagne C, Meybeck A. Comparative activity of asiaticoside and madecassoside on type I and III collagen synthesis by cultured human fibroblasts. Ann Pharm Fr 1995; 53: 38-42.
13. Centellae asiaticae herba. ESCOP monographs- the Scientific Foundation for Herbal Medicine Products-2nd Edition, Supplement 2009. ESCOP-Thieme, 2nd Edition.
14. Hentschel C, Dressler S, Hahn EG. Fumaria officinalis (fumitory)--clinical applications. Fortschritte der Medizin [1995, 113(19):291-292]
15. Ruperez P. et al. Potential Antioxidant Capacity of Sulfated Polysaccharides from the Edible Marine Brown Seaweed Fucus vesiculosus. J. Agric. Food Chem., 2002, 50 (4), pp 840–845
16. Moro CO et al. Obesity and medicinal plants. Fitoterapia. Volume 71, Supplement 1, 1 August 2000, Pages S73–S82
17. Burtin P. Nutritional value of seaweeds. 2003 Electron. J. Environ. Agric. Food Chem. ISSN 1579-4377
18. Chang, J., 1983. "Experimental study of antitumor effect of an extract derived from Zhu-Ling (Polyporus umbellatus)." Institute of Materia Medica, Academy of Traditional Chinese Medicine, Peking, China.
19. Chang, H.M. & P.P. But, 1986. Pharmacology and Applications of Chinese Materia Medica. Vol. 1. Singapore, World Scientific.
20. Haranaka, K., N. Satomi, A. Sakurai, R. Haranaka, N. Okada & M. Kobayishi, 1985. "Antitumor activities and tumor necrosis factor producibility of traditional Chinese medicines and crude drugs." Cancer Immunology & Immunotherapy 20(1): 1-5.
21. Y Sun and K Yasukawa New anti-inflammatory ergostane-type ecdysteroids from the sclerotium of Polyporus umbellatus. Bioorg Med Chem Lett, June 1, 2008; 18(11): 3417-20.
22. Inaoka Y, Shakuya A, Fukazawa H, Ishida H, Nukaya H, Tsuji K, Kuroda H, Okada M, Fukushima M, Kosuge T.Studies on active substances in herbs used for hair treatment. I. Effects of herb extracts on hair growth and isolation of an active substance from Polyporus umbellatus F. Chem Pharm Bull (Tokyo). 1994 42(3):530-3.
23. Ishida H, Inaoka Y, Shibatani J, Fukushima M, Tsuji K. Studies of the active substances in herbs used for hair treatment. II. Isolation of hair regrowth substances, acetosyringone and polyporusterone A and B, from Polyporus umbellatus Fries. Biol Pharm Bull. 1999 22(11):1189-92.
24. Ito H, Naruse S, Sugiura M.[Studies on antitumor activities of Basidiomycetes-antitumor activity of polysaccharides and sex factors] Nippon Yakurigaku Zasshi. 1976 72(1):77-94. Japanese.
25. Lee WY, Park Y, Ahn JK, Park SY, Lee HJ. Cytotoxic activity of ergosta-4,6,8(14),22-tetraen-3-one from the sclerotia of Polyporus umbellatus. Bull Kor Chem Soc. 2005 26(9):1464-6.
26. Li JJ, Tu YY, Tong JZ, Wang PT.[Inhibitory activity of Dianthus superbus L. and 11 kinds of diuretic Traditional Chinese medicines for urogenital Chlamydia trachomatis in vitro]Zhongguo Zhong Yao Za Zhi. 2000 25(10):628-30. Chinese.
27. Li, Q., S. Wang & C. Sun, 1992. "Clinical study of rapid bladder filling agent." Chang-Kuo-Chung-Hsi-I-Chieh-Ho-Tsa-Chih Sept. (12) 9: 533-4, 517.
28. Lin, Y.F. & G.L. Wu, 1988. "Protective effect of Polyporus umbellatus polysaccharide on toxic hepatitis in mice." Zhongguo Yao Li Xue Bao. Jul;9(4):345-8.
29. Liu, J.P., H. McIntosh & H. Lin, 2001. "Chinese medicinal herbs for chronic hepatitis B." Cochrane Database Syst Rev. (1):CD001940. Review.
30. Liu F, Ooi VEC, Chang ST.Free radical scavenging activities of mushroom polysaccharide extracts. Life Sciences. 1997 60(10):763-71.
31. Liu J, McIntosh H, Lin H.Chinese medicinal herbs for chronic hepatitis B: a systematic review. Liver. 2001 21(4):280-6. Review.
32. Lovy, A., B. Knowles, R. Labbe & L. Nolan, 1999. "Activity of edible mushrooms against the growth of human T4 leukemia cancer cells, and Plasmodium falciparum." Journal of Herbs, Spices & Medicinal Plants vol. 6(4): 49-57.
33. Miyasaki, T., 1983. "Antitumor activity of fungal crude drugs." Journal of Traditional Japanese Medicine 4(1), 61-65.
34. Ohsawa T, Yukawa M, Takao C, Murayama M, Bando H. Studies on constituents of fruit body of Polyporus umbellatus and their cytotoxic activity. Chem Pharm Bull (Tokyo). 1992 40(1):143-7.
35. Ohtsuka S, Ueno S, Yoshikumi C, Hirose F, Ohmura Y, Wada T, Fujii T, Takahashi E. Polysaccharides having an anticarcinogenic effect and a method of producing them from species of Basidiomycetes. UK Patent 1331513, 26 September 1973.
36. Satish H, Raman D, Shivananda BG, Kshama D, Rajesh MS, Deepak M, Shivananda TN. Antiurolithiatic herbal drugs - a review. Biomed. 2006 1(2):95-119.
37. Sekiya N, Hikiami H, Nakai Y, Sakakibara I, Nozaki K, Kouta K, Shimada Y, Terasawa K. Inhibitory effects of triterpenes isolated from Chuling (Polyporus umbellatus) Fries on free radical-induced lysis of red blood cells.Biol Pharm Bull. 2005 28(5):817-21.
38. Sun A, Chia JS, Chiang CP, Hsuen SP, Du JL, Wu CW, Wang WB. The Chinese herbal medicine Tien-Hsien liquid inhibits cell growth and induces apoptosis in a wide variety of human cancer cells J Altern Comp Med. 2005 11(2):245-56.
39. Sun, Y. & K. Yasukawa, 2008. "New anti-inflammatory ergostane-type ecdysteroids from the sclerotium of Polyporus umbellatus." Bioorg Med Chem Lett. Jun 1;18(11):3417-20. Epub 2008 Apr 7.
40. Wang LW, Su CY, LiuKS, ChangI. [Preliminary report on the diuretic action of Grifola umbellata.] Yao Xue Xue Bao. 1964 11:815-8. Chinese. No abstract available.
41. Wu GS, Zhang LY, Okuda H. [Inhibitive effect of Umbellatus polyporus polysaccharide on cachexic manifestation induced by toxohormone-L in rats] Zhongguo Zhong Xi Yi Jie He Za Zhi. 1997 17(4):232-3. Chinese.
42. Yadomae T, Suzuki I, Yonekubo H, Nunomura K, Miyazaki T. Examination of the mitogenic activity of materials from fungi on murine lymphocytes in vitro. Microbiology and Immunology. 1979 23(8):815-9.
43. Yang D, Li S, Wang H, Li X, Liu S, Han W, Hao J, Zhang H. [Prevention of postoperative recurrence of bladder cancer: a clinical study] Zhonghua Wai Ke Za Zhi. 1999 37(8):464-5. Chinese.
44. Yang DA. [Inhibitory effect of Chinese herb medicine Zhuling on urinary bladder cancer. An experimental and clinical study] Zhonghua Wai Ke Za Zhi. 1991 29(6):393-5, 399. Chinese.
45. Yang DA, Li SQ, Li XT. [Prophylactic effects of Zhuling and BCG on postoperative recurrence of bladder cancer] Zhonghua Wai Ke Za Zhi. 1994 32(7):433-4. Chinese.
46. Yang LJ, Wang RT, Liu JS, Tong H, Deng YQ, Li QH. [The effect of Polyporus umbellatus polysaccharide on the immunosuppression property of culture supernatant of S180 cells] Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2004 20(2):234-7. Chinese.
47. Yang, D.A., 1991. "Inhibitory effect of Chinese herb medicine on urinary bladder cancer. An experimental and clinical study." Chung-Hua-Wai-Ko-Tsa-Chih Jun. 29(6): 393-5, 399.
48. You JS, Hau DM, Chen KT, Huang HF. Combined effects of Chuling (Polyporus umbellatus) extract and mitomycin C on experimental liver cancer. Am J Chin Med. 1994 22(1):19-28.
49. Yuan D, Mori J, Komatsu KI, Makino T, Kano Y. An anti-aldosteronic diuretic component (drain dampness) in Polyporus sclerotium. Biol Pharm Bull. 2004 27(6):867-70.
50. Zhang YH, Liu YL, Yan SC. [Effect of Polyporus umbellatus polysaccharide on function of macrophages in the peritoneal cavities of mice with liver lesions] Zhong Xi Yi Jie He Za Zhi. 1991 11(4):225-6. Chinese.
51. Zhang, J., 1992. "A study on the role of immunosuppression in the pathogenesis of brucellosis." Zhongguo Yi Xue Ke Xue Yuan Xue Bao Jun;14(3):168-72.
52. Zhang, J., B. Gao, C. Cun, X. Lu, H. Wang, X. Chen & L. Tang, 1993. "Immunosuppression in murine brucellosis." Chin Med Sci J. Sep;8(3):134-8.
53. Zheng SZ, Yang HP, Ma XM, Shen XW. Two new polyporusterones from Polyporus umbellatus. Nat Prod Res. 2004 18(5):403-7.
54. Xiong, L.L., 1993. "Therapeutic effect of combined therapy of Salvia miltiorrhizae and Polyporus umbellatus polysaccharide in the treatment of chronic hepatitis B." Zhongguo Zhong Xi Yi Jie He Za Zhi Sep;13(9):533-5, 516-7.
55. Yan, S.C., 1988. "Clinical and experimental research on Polyporus umbellatus polysaccharide in the treatment of chronic viral hepatitis." Zhong Xi Yi Jie He Za Zhi Mar;8(3):141-3, 131.
56. Zhao YY et al. Bioactivity-directed isolation, identification of diuretic compounds from Polyporus umbellatus. J Ethnopharmacol. 2009 Oct 29;126(1):184-7.
57. Zhang G et al. Diuretic activity and kidney medulla AQP1, AQP2, AQP3, V2R expression of the aqueous extract of sclerotia of Polyporus umbellatus FRIES in normal rats. J Ethnopharmacol. 2010 Mar 24;128(2):433-7.
58. Zhao YY. Traditional uses, phytochemistry, pharmacology, pharmacokinetics and quality control of Polyporus umbellatus (Pers.) Fries: a review. J Ethnopharmacol. 2010 Mar 24;128(2):433-7.
59. Fernando Piterà. Compendio di Gemmoterapia clinica. 2000 (3° ed.) De Ferrari Editore
60. T. Swenson. Gemmoterapia. Mediterranee, Roma 1981.
61. He fJ, macGregor Ga. beneficial effects of potassium on human health. Physiol Plant. 2008;133(4):725-35.
62. Houston mc, Harper KJ. Potassium, magnesium, and calcium: their role in both the cause and treatment of hypertension. J clin Hypertens (Greenwich). 2008;10 (7 suppl 2):3-11.
63. Jaitovich a, bertorello am. salt, Na+,K+- atPase and hypertension. life sci. 2010;86(3-4):73-8
64. Aaron KJ et al. Role of dietary salt and potassium intake in cardiovascular health and disease: a review of the evidence. Mayo Clin Proc. 2013 Sep;88(9):987-95.



Vedi Anche